| 摘要 |
FIELD: medicine.SUBSTANCE: method involves conducting blood analysis and determining a mitochondrial fluorescence both in an initial state, and after adding a blood sample with an examined in vitro metabolic corrector in a dose equal to a recommended single dose, and calculating fluorescence gain rates. If the mitochondrial fluorescence gain rate under the action of the metabolic corrector is >0, the mitochondria are considered activated under the action of the metabolic corrector in a specific patient, whereas the derived gain rate of <0 enables to state the depressed mitochondrial function under the action of the metabolic corrector in a specific patient.EFFECT: presented method enables to determine the patient's individual sensitivity to a specific metabolic corrector for the purpose of the individual selection of a medicinal product and further effective treatment of the patients suffering from ischemic heart disease.1 ex, 5 dwg |
